넥스트바이오메디컬

389650KOSDAQSector: Electronics & Semiconductors

₩33,950▼ 3.00%Market cap ₩281.0BAs of Jul 21, 2026 close · updated once daily

Grade B55.2 ptsTop 44% of 2,523 stocks

Financial strength

60.2

Growth momentum

86.9

Price attractiveness

26.9

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

60.2

How much debt does it carry relative to equity?

Debt-to-equity ratio

23.2%

✓ Above median · Top 19.7% in sector

Sector median 61.3%

Can it cover what's due within a year?

Current ratio

537.9%

✓ Above median · Top 14.6% in sector

Sector median 185.8%

How much of revenue becomes profit?

Operating margin

-4.4%

✗ Below median · Top 67% in sector

Sector median 2.0%

How much did it earn on its own capital?

ROE (return on equity)

-0.6%

✗ Below median · Top 57.9% in sector

Sector median 2.1%

Source filing: annual report (separate) — view original ↗

Growth momentum

86.9

How much did revenue grow in a year?

Revenue growth (YoY)

72.7%

✓ Above median · Top 5% in sector

Sector median 4.4%

Did core profits grow in a year?

Operating income change (YoY)

79.9%

✓ Above median · Top 21.3% in sector

Sector median 1.9%

Source filing: annual report (separate) — view original ↗

Price attractiveness

26.9

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 56.8% in sector

Sector median P/E of profitable peers 16.7x · 44% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

5.84x

✗ Below median · Top 89.4% in sector

Sector median 1.16x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 490 stocks in Electronics & Semiconductors

S6A114B140C74D103F47